The Spreading Healthcare Access, Activities, Research and Knowledge (SHAARK) QUERI Program

传播医疗保健获取、活动、研究和知识 (SHAARK) QUERI 计划

基本信息

  • 批准号:
    10188846
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-10-01 至 2025-09-30
  • 项目状态:
    未结题

项目摘要

Background: Healthcare systems face the challenge of delivering care of the highest possible quality while simultaneously ensuring broad access to services and prudent use of resources. Without thoughtfully designed implementation strategies, the impact of evidence-based practices (EBPs) cannot be fully realized because it is difficult to spread the EBP beyond early adopting facilities. The Spreading Healthcare Access, Activities, Research and Knowledge (SHAARK) QUERI will compare implementation strategies for EBPs in two areas of high relevance to VA: addressing the needs of veterans suffering from moral pain (e.g., guilt, shame, betrayal) as a result of actions taken or not taken during their service (aka, moral injury) and veterans who face the substantial health risks of persistently poor diabetes control. While these groups are important in-and-of themselves, the synergy that comes from studying implementation of distinct EBPs aimed at different complex health conditions will lead to a greater understanding of how to address the overarching implementation challenge of moving clinical EBPs across health systems. Significance/Impact: In alignment with VA facility and VISN Director Performance Plan metrics to identify and spread innovations, the SHAARK QUERI will provide evidence for how VA and other healthcare systems can use strategies for spreading complex clinical EBPs beyond successful earlier adopters across the healthcare system. This evidence will be obtained by conducting clinical trials of an implementation strategy aligning with the Exploration, Preparation, Implementation, Sustainment (EPIS) implementation framework, while specifically seeking to improve care for moral injury and persistently uncontrolled diabetes. Specific Aims: Using two EBPs, Advanced Comprehensive Diabetes Care (ACDC) and Moral Injury Groups, we will conduct two hybrid type 3 implementation trials that align with the EPIS framework for the establishment of strategies to implement EBPs. The specific aims are as follows: Aim 1a: Measure difference in the percentage of patients receiving appropriate dose/adherence to group attendance (attending ≥ 80% of group sessions) as an indication of fidelity; Aim 1b: Measure differences in the percentage of core components implemented and number of adaptations to EBP processes; Aim 1c: Examine differences in the number and intensity of quality improvement efforts/plan-do-study-act cycles undertaken by sites; Aim 2: Examine differences in change in PTSD symptoms, suicidal behavior, & perceived life significance (for Moral Injury Groups trial) and difference in change in hemoglobin A1c (for ACDC trial); Aim 3: Conduct evaluation of implementation process; and Aim 4: Build a business case including budget impact (for both EBP trials). Methods: We will test the implementation strategy, Dynamic Diffusion Network (DDN), for operationalizing EPIS (1 separate DDN per trial) for later adopters of EBPs. The DDN will be compared to technical assistance. For each trial, 10 VA facilities will be randomized to implement the EBP using either the Dynamic Diffusion Network EPIS implementation strategy (5 sites) or technical assistance (5 sites). Primary outcomes will be focused on successful implementation of the EBPs, use of EBP components, and rapid improvement processes, as well as secondary clinical outcomes of the practice. Program materials previously used for both EBPs will be refined into an initial change package/implementation toolkit to be shared with each interested site. The toolkits will be assessed by two frontline staff members who have had previous experience implementing the EBPs. We will also conduct a formative evaluation of both EBPs to explore factors potentially influencing outcomes at each EPIS stage based on the Consolidated Framework for Implementation Research (CFIR). The evaluation will use a mixed methods approach consisting of semi-structured, qualitative interviews, surveys and other complementary methods with participating VA sites. A business case will be developed based on a balanced scorecard approach, accounting for outcomes, cost, and implementation.
背景:医疗保健系统面临的挑战是提供尽可能高质量的护理, 同时确保广泛获得服务和谨慎使用资源。没有经过深思熟虑 设计的实施战略,循证实践(EBP)的影响无法充分实现 因为很难将EBP扩展到早期采用的设施之外。扩大医疗保健的可及性, 活动、研究和知识(SHAARK) 与退伍军人事务部高度相关的领域:解决遭受道德痛苦的退伍军人的需求(例如,内疚羞愧 背叛)由于在服役期间采取或不采取的行动(又名,精神伤害)和面临 糖尿病控制持续不佳的重大健康风险。虽然这些群体在 他们自己,来自研究不同的EBP的实施,旨在不同的复杂的协同作用, 健康状况将使人们更好地了解如何解决总体实施问题 将临床EBP转移到卫生系统的挑战。 重要性/影响:与VA机构和VISN总监绩效计划指标保持一致,以识别和 传播创新,SHAARK QUERI将为VA和其他医疗保健系统如何 使用策略将复杂的临床EBP传播到整个医疗保健领域的成功早期采用者之外 系统将通过对符合以下要求的实施策略进行临床试验来获得这些证据: 探索、准备、实施和维持(EPIS)实施框架, 寻求改善对精神伤害和持续不受控制的糖尿病的护理。 具体目标:使用两个EBP,高级综合糖尿病护理(ACDC)和道德伤害组, 我们将进行两项与EPIS框架相一致的第3类混合实施试验, 制定实施循证优先事项的战略。具体目标如下:目标1a:衡量差异 接受适当剂量/坚持分组就诊的患者百分比(≥ 80%的 目标1b:衡量核心组成部分百分比的差异 目标1c:审查对EBP流程的调整数量和 研究中心开展的质量改进工作/计划-实施-研究-行动周期的强度;目标2:检查 PTSD症状、自杀行为和感知生活意义(精神伤害)的变化差异 组试验)和血红蛋白A1 c变化的差异(ACDC试验);目的3: 目标4:建立一个商业案例,包括预算影响(针对两个EBP试验)。 方法:我们将测试实施策略,动态扩散网络(DDN),用于操作 EPIS(每次试验1个单独的DDN),用于以后采用EBP的人。DDN将与技术 援助.对于每项试验,将随机分配10家VA机构,使用动态 传播网络环境政策信息系统实施战略(5个地点)或技术援助(5个地点)。主要结局 将重点关注电子商务计划的成功实施、电子商务计划组成部分的使用和快速改进 过程,以及实践的次要临床结果。以前用于这两种用途的方案材料 将改进电子商务计划,使之成为一个初步的改革包/实施工具包,与每个感兴趣的人分享。 绝佳的价钱两名有经验的前线人员会评估这些工具包 实施EBPs。我们还将对这两个EBP进行形成性评估,以探索潜在的因素 根据实施研究的综合框架,影响EPIS每个阶段的成果 (CFIR)。评估将采用混合方法,包括半结构化、定性和定量评估。 访谈、调查和其他补充方法。商业案例将是 根据平衡计分卡方法制定,考虑成果、成本和实施。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Leveraging Organizational Conditions for Innovation: A Typology of Facility Engagement in the Veterans Health Administration Shark Tank-Style Competition.
  • DOI:
    10.7812/tpp/22.154
  • 发表时间:
    2023-06-15
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kaitz J;DeLaughter K;Deeney C;Cutrona SL;Hogan TP;Gifford AL;Jackson GL;White B;King H;Reardon C;Nevedal A;Henderson B;Fix GM
  • 通讯作者:
    Fix GM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew J. Crowley其他文献

Telehealth Treatment for Alcohol Misuse: Reviewing Telehealth Approaches to Increase Engagement and Reduce Risk of Alcohol-Related Hypertension
  • DOI:
    10.1007/s11906-019-0966-3
  • 发表时间:
    2019-06-17
  • 期刊:
  • 影响因子:
    5.100
  • 作者:
    Dan V. Blalock;Patrick S. Calhoun;Matthew J. Crowley;Eric A. Dedert
  • 通讯作者:
    Eric A. Dedert
Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents
接触新型钆剂后发生肾源性系统纤维化的风险
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    39.2
  • 作者:
    Joseph Lunyera;Dinushika Mohottige;A. Alexopoulos;Hilary Campbell;C. Cameron;N. Sagalla;T. Amrhein;Matthew J. Crowley;J. Dietch;Adelaide M Gordon;A. Kosinski;S. Cantrell;John W. Williams;J. Gierisch;Belinda Ear;K. Goldstein
  • 通讯作者:
    K. Goldstein
Cardiometabolic Comorbidities in Cancer Survivors: emJACC: CardioOncology/em State-of-the-Art Review
癌症幸存者中的心血管代谢合并症:emJACC:心血管肿瘤学/最新技术综述
  • DOI:
    10.1016/j.jaccao.2022.03.005
  • 发表时间:
    2022-06-01
  • 期刊:
  • 影响因子:
    12.800
  • 作者:
    Leah L. Zullig;Anthony D. Sung;Michel G. Khouri;Shelley Jazowski;Nishant P. Shah;Andrea Sitlinger;Dan V. Blalock;Colette Whitney;Robin Kikuchi;Hayden B. Bosworth;Matthew J. Crowley;Karen M. Goldstein;Igor Klem;Kevin C. Oeffinger;Susan Dent
  • 通讯作者:
    Susan Dent
Diabetes Quality of Care Before and After Implementation of a Resident Clinic Practice Partnership System
实施住院医师实践合作系统前后的糖尿病护理质量
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    1.4
  • 作者:
    E. Campbell;Matthew J. Crowley;Benjamin J. Powers;L. Sanders;M. Olsen;Susanne M. Danus;D. Mcneill;A. Zaas
  • 通讯作者:
    A. Zaas
Inherited lipemic splenomegaly and the spectrum of apolipoprotein E p.Leu167del mutation phenotypic variation.
遗传性脂血性脾肿大和载脂蛋白E p.Leu167del 突变表型变异谱。
  • DOI:
    10.1016/j.jacl.2013.09.003
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Daniel E Okorodudu;Matthew J. Crowley;Siby Sebastian;J. Rowell;J. Guyton
  • 通讯作者:
    J. Guyton

Matthew J. Crowley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew J. Crowley', 18)}}的其他基金

EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND)
扩展由技术支持、护士提供的慢性病护理 (EXTEND)
  • 批准号:
    10093847
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND)
扩展由技术支持、护士提供的慢性病护理 (EXTEND)
  • 批准号:
    10371975
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND)
扩展由技术支持、护士提供的慢性病护理 (EXTEND)
  • 批准号:
    10546494
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Practical Telemedicine to Improve Control and Engagement for Veterans with Clinic-Refractory Diabetes Mellitus (PRACTICE-DM)
实用远程医疗可改善患有临床难治性糖尿病的退伍军人的控制和参与(PRACTICE-DM)
  • 批准号:
    9706639
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Practical Telemedicine to Improve Control and Engagement for Veterans with Clinic-Refractory Diabetes Mellitus (PRACTICE-DM)
实用远程医疗可改善患有临床难治性糖尿病的退伍军人的控制和参与(PRACTICE-DM)
  • 批准号:
    10186530
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Tailored, eHealth-based Management for Persistent Poorly-Controlled Diabetes
针对持续性控制不佳的糖尿病的定制化、基于电子健康的管理
  • 批准号:
    9981441
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Tailored, eHealth-based Management for Persistent Poorly-Controlled Diabetes
针对持续性控制不佳的糖尿病的定制化、基于电子健康的管理
  • 批准号:
    10176574
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Tailored, eHealth-based Management for Persistent Poorly-Controlled Diabetes
针对持续性控制不佳的糖尿病的定制化、基于电子健康的管理
  • 批准号:
    8783676
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了